These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 869020)

  • 21. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
    Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
    Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and treatment of acute intestinal obstruction in cancer of the large intestine].
    Alipov VV
    Vestn Khir Im I I Grek; 1985 Aug; 135(8):44-8. PubMed ID: 4060508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local immunotherapy of stomach and intestinal carcinoma by Propionibacterium granulosum.
    Gil J; Orlowski T; Nowakowski W; Ko HL; Roszkowski K; Roszkowski W; Szmigielski S; Pulverer G; Jeljaszewicz J
    Dis Colon Rectum; 1980; 23(8):536-43. PubMed ID: 6970114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating blocking factors of lymphoid-cell cytotoxicity in X-ray-induced rat small-bowel adenocarcinoma.
    Stevens RH; Brooks GP; Osborne JW
    Radiat Res; 1979 Oct; 80(1):161-9. PubMed ID: 504568
    [No Abstract]   [Full Text] [Related]  

  • 26. [Carcinoembryonic antigens (CES) in malignant tumors of the colon and rectum].
    Orjasaeter H; Liavåg I; Fredriksen G
    Tidsskr Nor Laegeforen; 1972 Mar; 92(7):497-501. PubMed ID: 4624694
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemo-immunotherapy with levamisole in metastatic breast carcinoma: a controlled clinical trial.
    Paterson AH; Edwards AM; Nutting M; Schinnour D; Takats L; McClelland A
    Cancer Clin Trials; 1980; 3(1):5-10. PubMed ID: 6993035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On carcinoma of the large intestine, with special reference to the juvenile age].
    Ferrari de Gaetani C; Muscatelli M
    Arch Ital Patol Clin Tumori; 1967; 10(1):41-79. PubMed ID: 4300481
    [No Abstract]   [Full Text] [Related]  

  • 29. [Primary multiple cancer of the large intestine and other organs].
    Nadzharov AG; Ismaĭlova ZIu; Sadykhov VI
    Vestn Khir Im I I Grek; 1973 Jan; 109(1):75-9. PubMed ID: 4351408
    [No Abstract]   [Full Text] [Related]  

  • 30. Five-year experience with levamisole in cancer patients.
    Debois JM
    Ther Hung; 1981; 29(1):15-20. PubMed ID: 7188236
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunomorphological study of 1,2-dimethylhydrazine-induced carcinomas of the large intestine in rats using monoclonal antibodies to intermediate filament proteins].
    Krutovskikh VA; Troianovskiĭ SM
    Biull Eksp Biol Med; 1985 Aug; 100(8):240-1. PubMed ID: 3896343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gallstones and carcinoma of the large bowel.
    Doouss TW; Castleden WM
    N Z Med J; 1973 Mar; 77(490):162-5. PubMed ID: 4512660
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoprevention of large bowel cancer: an animal model.
    Sjögren HO
    Cancer; 1980 Mar; 45(5 Suppl):1229-33. PubMed ID: 7357514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of immunotherapy and spleen preservation on immunological function in patients with gastric cancer.
    Okinaga K; Iinuma H; Kitamura Y; Yokohata T; Inaba T; Fukushima R
    J Exp Clin Cancer Res; 2006 Sep; 25(3):339-49. PubMed ID: 17167974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The characteristics of the phagocytic and metabolic activities of the neutrophilic granulocytes in diseases of the large intestine].
    Saenko VF; Stasenko AA; Pavlovskaia MN; Pustovit AA; Lavrik AS
    Klin Khir; 1995; (2):12-4. PubMed ID: 9053176
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
    Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
    Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of enteral feeding in the surgical treatment of patients with cancer of the stomach and large intestine].
    Pronin VI; Sarantsev AN; Syzrantsev IuK
    Sov Med; 1984; (5):17-21. PubMed ID: 6431615
    [No Abstract]   [Full Text] [Related]  

  • 38. [Enterosorption in the preoperative period in patients with cancer of the large intestine].
    Martyniuk VV; Beliakov NA; Fridman MKh; Solomennikov AV
    Vopr Onkol; 1989; 35(4):441-5. PubMed ID: 2728385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The large intestine as a geriatric problem.
    Strode JE
    Geriatrics; 1968 Jul; 23(7):102-12. PubMed ID: 5658991
    [No Abstract]   [Full Text] [Related]  

  • 40. Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.
    Loveland BE; Zhao A; White S; Gan H; Hamilton K; Xing PX; Pietersz GA; Apostolopoulos V; Vaughan H; Karanikas V; Kyriakou P; McKenzie IF; Mitchell PL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):869-77. PubMed ID: 16467101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.